vs
Encompass Health Corp（EHC）とQVC Group, Inc.（QVCGA）の財務データ比較。上の社名をクリックして会社を切り替えられます
QVC Group, Inc.の直近四半期売上が大きい（$2.7B vs $1.5B、Encompass Health Corpの約1.7倍）。Encompass Health Corpの純利益率が高く（9.5% vs -1.4%、差は10.8%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs -9.1%）。QVC Group, Inc.の直近四半期フリーキャッシュフローが多い（$191.0M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 6.9%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
QVCグループはアメリカのメディア複合企業で、会長のジョン・C・マローンによって支配されています。マローンは同社の議決権付き株式の過半数を保有しており、アメリカ国内で影響力のあるメディアグループの一つです。
EHC vs QVCGA — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $2.7B |
| 純利益 | $146.1M | $-37.0M |
| 粗利率 | — | 32.9% |
| 営業利益率 | 16.7% | 3.7% |
| 純利益率 | 9.5% | -1.4% |
| 売上前年比 | 9.9% | -9.1% |
| 純利益前年比 | 20.8% | 97.1% |
| EPS（希薄化後） | $1.43 | $-17.37 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $2.7B | ||
| Q3 25 | $1.5B | $2.2B | ||
| Q2 25 | $1.5B | $2.2B | ||
| Q1 25 | $1.5B | $2.1B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.4B | $2.3B | ||
| Q2 24 | $1.3B | $2.4B | ||
| Q1 24 | $1.3B | $2.3B |
| Q4 25 | $146.1M | $-37.0M | ||
| Q3 25 | $126.5M | $-80.0M | ||
| Q2 25 | $142.1M | $-2.2B | ||
| Q1 25 | $151.5M | $-100.0M | ||
| Q4 24 | $120.9M | $-1.3B | ||
| Q3 24 | $108.2M | $-23.0M | ||
| Q2 24 | $114.1M | $20.0M | ||
| Q1 24 | $112.5M | $-1.0M |
| Q4 25 | — | 32.9% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 36.4% | ||
| Q1 25 | — | 34.2% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | — | 35.3% | ||
| Q2 24 | — | 36.4% | ||
| Q1 24 | — | 35.5% |
| Q4 25 | 16.7% | 3.7% | ||
| Q3 25 | 14.9% | 2.7% | ||
| Q2 25 | 16.2% | -101.6% | ||
| Q1 25 | 16.4% | 0.7% | ||
| Q4 24 | 14.3% | -43.2% | ||
| Q3 24 | 13.6% | 6.5% | ||
| Q2 24 | 14.3% | 6.9% | ||
| Q1 24 | 13.6% | 6.2% |
| Q4 25 | 9.5% | -1.4% | ||
| Q3 25 | 8.6% | -3.6% | ||
| Q2 25 | 9.7% | -99.4% | ||
| Q1 25 | 10.4% | -4.8% | ||
| Q4 24 | 8.6% | -43.7% | ||
| Q3 24 | 8.0% | -1.0% | ||
| Q2 24 | 8.8% | 0.8% | ||
| Q1 24 | 8.5% | -0.0% |
| Q4 25 | $1.43 | $-17.37 | ||
| Q3 25 | $1.24 | $-9.89 | ||
| Q2 25 | $1.39 | $-275.46 | ||
| Q1 25 | $1.48 | $-0.25 | ||
| Q4 24 | $1.18 | — | ||
| Q3 24 | $1.06 | $-0.06 | ||
| Q2 24 | $1.12 | $2.57 | ||
| Q1 24 | $1.10 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $2.0B |
| 総負債低いほど良い | $2.4B | $790.0M |
| 株主資本純資産 | $2.4B | $-3.1B |
| 総資産 | $7.1B | $7.6B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $2.0B | ||
| Q3 25 | $48.7M | $1.8B | ||
| Q2 25 | $99.1M | $897.0M | ||
| Q1 25 | $95.8M | $833.0M | ||
| Q4 24 | $85.4M | $905.0M | ||
| Q3 24 | $147.8M | $873.0M | ||
| Q2 24 | $154.4M | $1.2B | ||
| Q1 24 | $134.4M | $1.1B |
| Q4 25 | $2.4B | $790.0M | ||
| Q3 25 | $2.4B | $5.9B | ||
| Q2 25 | $2.3B | $4.9B | ||
| Q1 25 | $2.3B | $5.0B | ||
| Q4 24 | $2.4B | $4.1B | ||
| Q3 24 | $2.3B | $5.1B | ||
| Q2 24 | $2.7B | $5.3B | ||
| Q1 24 | $2.7B | $5.5B |
| Q4 25 | $2.4B | $-3.1B | ||
| Q3 25 | $2.4B | $-3.1B | ||
| Q2 25 | $2.3B | $-3.0B | ||
| Q1 25 | $2.2B | $-981.0M | ||
| Q4 24 | $2.1B | $-971.0M | ||
| Q3 24 | $2.0B | $397.0M | ||
| Q2 24 | $1.8B | $328.0M | ||
| Q1 24 | $1.7B | $255.0M |
| Q4 25 | $7.1B | $7.6B | ||
| Q3 25 | $6.9B | $7.6B | ||
| Q2 25 | $6.8B | $6.7B | ||
| Q1 25 | $6.6B | $9.0B | ||
| Q4 24 | $6.5B | $9.2B | ||
| Q3 24 | $6.5B | $10.8B | ||
| Q2 24 | $6.4B | $10.9B | ||
| Q1 24 | $6.2B | $11.0B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | 12.74× | ||
| Q2 24 | 1.46× | 16.28× | ||
| Q1 24 | 1.54× | 21.53× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $244.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $191.0M |
| FCFマージンFCF / 売上 | 7.6% | 7.1% |
| 設備投資強度設備投資 / 売上 | 14.8% | 2.0% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | — |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $118.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $244.0M | ||
| Q3 25 | $270.8M | $4.0M | ||
| Q2 25 | $270.2M | $86.0M | ||
| Q1 25 | $288.6M | $-60.0M | ||
| Q4 24 | $278.8M | $212.0M | ||
| Q3 24 | $267.8M | $20.0M | ||
| Q2 24 | $217.4M | $267.0M | ||
| Q1 24 | $238.8M | $26.0M |
| Q4 25 | $116.7M | $191.0M | ||
| Q3 25 | $83.7M | $-27.0M | ||
| Q2 25 | $113.3M | $48.0M | ||
| Q1 25 | $125.5M | $-94.0M | ||
| Q4 24 | $80.1M | $150.0M | ||
| Q3 24 | $120.3M | $-23.0M | ||
| Q2 24 | $60.5M | $213.0M | ||
| Q1 24 | $99.4M | $-14.0M |
| Q4 25 | 7.6% | 7.1% | ||
| Q3 25 | 5.7% | -1.2% | ||
| Q2 25 | 7.8% | 2.1% | ||
| Q1 25 | 8.6% | -4.5% | ||
| Q4 24 | 5.7% | 5.1% | ||
| Q3 24 | 8.9% | -1.0% | ||
| Q2 24 | 4.6% | 8.8% | ||
| Q1 24 | 7.6% | -0.6% |
| Q4 25 | 14.8% | 2.0% | ||
| Q3 25 | 12.7% | 1.4% | ||
| Q2 25 | 10.8% | 1.7% | ||
| Q1 25 | 11.2% | 1.6% | ||
| Q4 24 | 14.1% | 2.1% | ||
| Q3 24 | 10.9% | 1.8% | ||
| Q2 24 | 12.1% | 2.2% | ||
| Q1 24 | 10.6% | 1.7% |
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 1.91× | 13.35× | ||
| Q1 24 | 2.12× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
QVCGA
| Other | $915.0M | 34% |
| Home | $754.0M | 28% |
| Beauty | $260.0M | 10% |
| Apparel | $254.0M | 9% |
| Electronics | $187.0M | 7% |
| Accessories | $181.0M | 7% |
| Jewelry | $87.0M | 3% |
| Manufactured Product Other | $38.0M | 1% |
